RIO

(redirected from Rimonabant in Obesity)
AcronymDefinition
RIORio De Janeiro, Rio De Janeiro, Brazil (Airport Code)
RIORisk, Issues, and Opportunities (various locations)
RIORemote Input Output
RIOReference Identifier Object
RIORam Input Output
RIORock in Opposition (musical genre)
RIORadar Intercept Officer
RIORapidIO (Interconnect Architecture)
RIORegionaal Indicatie Orgaan (Dutch: Regional Indication Body; health care)
RIORimonabant in Obesity
RIOReconfigurable Input/Output
RIOReference Interconnection Offer
RIORestore Iraqi Oil (US Army mission)
RIOReintegration of Offenders
RIORemote Input/Output
RIORight, I'm Off
RIOResearch Innovation Office (various locations)
RIORégie des Installations Olympiques
RIOReusable Information Object
RIOReshaping the International Order (book)
RIORegional Information Officer (USACE)
RIORetirement Income Option (various organizations)
RIORelevé d'Identité d'Opérateur (French: Statement of Identity Operator)
RIOResampled Inference of Orthologs
RIORemote Infrastructure Operations
RIORéseau Intertropical d'Ordinateurs (French: Intertropical Network of Computers)
RIOResearch Instruction Online
RIOReverse Implied Odds (Poker)
RIOReverse Implement Option (riding lawnmowers)
RIORoma Initiatives Office (Open Society Institute)
RIORandom Insanity Online (website)
RIOResolution Independent Object(s)
RIOReporting In & Out
RIORibbonized Organized Integrated (aircraft wiring)
RIORegional Inspection Officer (India)
RIORandom Early Discard with In/Out (algorithm)
RIORemote Inside Option (Compaq)
RIORealistic Input/Output Opportunity
References in periodicals archive ?
Van Gaal, professor of diabetology, metabolism, and clinical nutrition at the University of Antwerp (Belgium) and principal investigator for Rimonabant in Obesity (RIO)-Europe.
The Rimonabant in Obesity and Related Metabolic Disorders (RIO) trial series comprises four distinct international multicenter trials looking at the effects of the drug in nonoverlapping populations.
The latest of these trials, the Rimonabant in Obesity (RIO)--Diabetes study, suggests similar benefit among overweight and obese patients with type 2 diabetes.